1-17 of 17
Peter Kamper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pregnancies and Childbirth Following Advanced-Stage Hodgkin Lymphoma Treatment with Brecadd or Beacopp in the Randomized Phase III GHSG HD21 Trial

Justin Ferdinandus, Gundolf Schneider, Alexander Fosså, Alden Moccia, Richard Greil, Mark S. Hertzberg, Josée M. Zijlstra, Peter Kamper, Daniel L. Molin, Andrea Kerkhoff, Sebastian Scholl, Yon-Dschun Ko, Max S. Topp, Joachim Beck, Vladan Vucinic, Wolfram Jung, Roland Schroers, Andreas Rank, Carla Damaschin, Anne Sophie Jacob, Michael Fuchs, Peter Borchmann, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4437.
https://doi.org/10.1182/blood-2023-188449
Published: 2023
Journal Articles

Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial

Peter Borchmann, Alden Moccia, Richard Greil, Gundolf Schneider, Mark S. Hertzberg, Valdete Schaub, Andreas Huettmann, Felix Keil, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel L. Molin, Stefanie Kreissl, Justin Ferdinandus, Michael Fuchs, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl
Journal: Blood
Blood (2023) 142 (Supplement 1): 3057.
https://doi.org/10.1182/blood-2023-188720
Published: 2023
Journal Articles

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients - a Nationwide Danish Cohort Study

Sara Rossetti, Sidsel Jacobsen Juul, Frank Eriksson, Peder Emil Warming, Charlotte Glinge, Tarec Christoffer Christoffer El-Galaly, Jacob Haaber Christensen, Peter Kamper, Peter de Nully Brown, Maja Maraldo, Jacob Tfelt-Hansen, Martin Hutchings
Journal: Blood
Blood (2023) 142 (Supplement 1): 4450.
https://doi.org/10.1182/blood-2023-172989
Published: 2023
Journal Articles

Age-Based Validation of the Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in a Real-World Danish Study: Suboptimal Performance in Older Patients

Rasmus Rask Kragh Jørgensen, Sandra Eloranta, Jacob Haaber Christensen, Martin Hutchings, Rasmus Bo Dahl-Soerensen, Peter Kamper, Andrew M Evens, Matthew J. Maurer, Susan K Parsons, Angie Mae Rodday, Jenica Upshaw, Tarec Christoffer Christoffer El-Galaly, Lasse Hjort Jakobsen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4455.
https://doi.org/10.1182/blood-2023-178498
Published: 2023
Journal Articles

Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group

Peter Borchmann, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Haenel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M. Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel Molin, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl, Andreas Engert
Journal: Blood
Blood (2022) 140 (Supplement 1): 771–773.
https://doi.org/10.1182/blood-2022-165917
Published: 2022
Journal Articles

Fertility Rates in Young Hodgkin Lymphoma Survivors: A Danish Nationwide Cohort Study of 769 Patients

Andreas Kiesbye Øvlisen, MD, Lasse H. Jakobsen, PhD, Kristian Hay Kragholm, Martin Hutchings, MD PhD, Henrik Frederiksen, MD PhD Prof, Peter Kamper, Sandra Eloranta, Caroline Weibull, Ingrid Glimelius, MD PhD, Karin Ekstrom Ekstroem Smedby, Marianne Tang Severinsen, MD PhD, Tarec Christoffer C. El-Galaly, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2841.
https://doi.org/10.1182/blood-2019-122642
Published: 2019
Journal Articles

B-CAP (brentuximab vedotin, cyclophosphamide, doxorubicin and predniso(lo)Ne) in Older Patients with Advanced-Stage Hodgkin Lymphoma: Results of a Phase II Intergroup Trial By the German Hodgkin Study Group (GHSG) and the Nordic Lymphoma Group (NLG)

Boris Boell, MD, Alexander Fosså, MD PhD, Helen Goergen, Peter Kamper, Sirpa Leppa, MD Prof, Daniel Molin, Julia Meissner, MD, Ellen Ritter, MD, Jacob H. Christensen, Martin Hutchings, MD, Michael Fuchs, Andreas Engert, MD, Carsten Kobe, MD, Peter Borchmann, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 926.
https://doi.org/10.1182/blood-2018-99-119363
Published: 2018
Journal Articles

The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

Michael Roost Clausen, MD, Sirpa Leppa, MD, Peter de Nully Brown, MD, Jette Soenderskov Goerloev, MD, Michael Panny, MD, Wolfgang Willenbacher, MD, Ida Blok Sillesen, MD, Erik Segel, MD, Hans Bentzen, MD, Michael Thorsgaard, MD, Elisa Jacobsen Pulczynski, MD, Peter Kamper, MD, Lars C. Gormsen, MD, Julie Mortensen, MDcal Student, Grethe Lauritzsen, MD, Thomas Relander, MD PhD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1782.
https://doi.org/10.1182/blood.V128.22.1782.1782
Published: 2016
Journal Articles

Identification of Novel Germline Variants in Early-Onset Familial Classical Hodgkin Lymphoma with Exome Sequencing

Outi Kilpivaara, PhD, Heikki Ristolainen, Peter Kamper, Minna Taskinen, PhD, Silva Saarinen, MD PhD, Sirpa Leppä, MD PhD, Francesco d'Amore, Aaltonen A. Lauri, Professor
Journal: Blood
Blood (2014) 124 (21): 4402.
https://doi.org/10.1182/blood.V124.21.4402.4402
Published: 2014
Journal Articles

Diffusely Increased Bone Marrow 18F-FDG Uptake Is an Independent Predictor of Focal Bone Lesions in Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Lars C. Gormsen, Cecilia Wassberg, Daniel Molin, Peter Kamper, Gunilla Enblad, Francesco d'Amore
Journal: Blood
Blood (2014) 124 (21): 5360.
https://doi.org/10.1182/blood.V124.21.5360.5360
Published: 2014
Journal Articles

Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas

Francesco d'Amore, Judit Joergensen, Ida Blok Sillesen, Erik Segel, Hans Bentzen, Michael Thorsgaard, Elisa Jacobsen Pulczynski, Bjarne Bach Pedersen, Dorte Gillström, Michael Clausen, Peter Kamper, Trine Silkjaer, Lars C. Gormsen, Sirpa Leppä, Helle Toldbod
Journal: Blood
Blood (2014) 124 (21): 5435.
https://doi.org/10.1182/blood.V124.21.5435.5435
Published: 2014
Journal Articles

Clinical Features and Outcome in Newly Diagnosed Hodgkin Lymphoma Patients Presenting with PET/CT-Ascertained Focal Skeletal Lesions.

Tarec Christoffer El-Galaly, Martin Hutchings, Karen Juul Mylam, Peter de Nully Brown, Anne Bukh, Peter Kamper, Hans Erik Johnsen, Francesco d'Amore
Journal: Blood
Blood (2012) 120 (21): 2637.
https://doi.org/10.1182/blood.V120.21.2637.2637
Published: 2012
Journal Articles

Epstein-Barr Virus Status Correlates with Composition and Prognostic Impact of the Tumor Microenvironment in Classical Hodgkin Lymphoma

Peter Kamper, Knud Bendix, Stephen Jacques Hamilton-Dutoit, Bent Honore, Francesco d'Amore
Journal: Blood
Blood (2012) 120 (21): 52.
https://doi.org/10.1182/blood.V120.21.52.52
Published: 2012
Journal Articles

Monocytosis in the Peripheral Blood At First Relapse/Progression Predicts Poorer Overall and Progression-Free Survival After Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma

Marie Toft-Petersen, Peter Kamper, Signe Albertsen, Louise Secher, Erik Kay Segel, Michael Clausen, Francesco d'Amore, MD, DMSci
Journal: Blood
Blood (2011) 118 (21): 1559.
https://doi.org/10.1182/blood.V118.21.1559.1559
Published: 2011
Journal Articles

Age-Adjusted Combined Immunochemotherapy without Radiotherapy in Newly Diagnosed PCNSL – A Phase II Trial of the Nordic Lymphoma Group

Elisa Jacobsen Pulczynski, Peter Kamper, Unn-Merete Fagerli, Martin Erlanson, Outi Kuittinen, Alexander Fosså, Bjørn Østenstad, Oystein Fluge, Martin Maisenhølder, Hans Hagberg, Mikael Eriksson, Marie Nordstrøm, Sirpa Leppa
Journal: Blood
Blood (2011) 118 (21): 1602.
https://doi.org/10.1182/blood.V118.21.1602.1602
Published: 2011
Journal Articles

Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma

Peter Kamper, Maja Ludvigsen, Knud Bendix, Stephen Hamilton-Dutoit, Gabriel A. Rabinovich, Michael Boe Møller, Jens R. Nyengaard, Bent Honoré, Francesco d'Amore
Journal: Blood
Blood (2011) 117 (24): 6638–6649.
https://doi.org/10.1182/blood-2010-12-327346
Published: 2011
Journal Articles

Correlation between Intratumoral Cellular Microenvironment, Clinicopathological Parameters and Prognosis in Hodgkin Lymphoma.

Peter Kamper, MD, Anne-Sofie Hammer, D.V.M, Stephen Hamilton-Dutoit, M.D, Knud Bendix, M.D., Bent Honoré, M.D., Francesco d’Amore, M.D.
Journal: Blood
Blood (2007) 110 (11): 2273.
https://doi.org/10.1182/blood.V110.11.2273.2273
Published: 2007